Krystal Biotech Stock In The News

KRYS Stock  USD 190.40  8.11  4.45%   
Our overall analysis of Krystal Biotech's news coverage and content from conventional and social sources shows investors' bearish mood towards Krystal Biotech. The specific impact of Krystal Biotech news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Krystal Biotech's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Krystal Biotech headlines in addition to utilizing other, more conventional financial analysis modules. Check out Krystal Biotech Backtesting and Krystal Biotech Hype Analysis.
For more information on how to buy Krystal Stock please use our How to Invest in Krystal Biotech guide.

Krystal Biotech Today Top News and Investor Outlook

Yahoo News
All You Need to Know About Krystal Biotech (KRYS) Rating Upgrade to Buy
https://finance.yahoo.com/news/know-krystal-biotech-krys-rating-160010967.html
 Bullish
Yahoo News
Exploring Three High Growth Tech Stocks in the United States
https://finance.yahoo.com/news/exploring-three-high-growth-tech-140248654.html
 Bullish
Yahoo News
US Growth Stocks With High Insider Ownership
https://finance.yahoo.com/news/us-growth-stocks-high-insider-193134920.html
 Bullish
Yahoo News
ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal
https://finance.yahoo.com/news/abbvs-newly-added-parkinsons-disease-174000909.html
 Bullish
Yahoo News
Pfizer Withdraws Sickle Cell Disease Therapy Oxbryta From Market
https://finance.yahoo.com/news/pfizer-withdraws-sickle-cell-disease-154000756.html
 Bullish
Yahoo News
CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease
https://finance.yahoo.com/news/chmp-endorses-astrazenecas-fasenra-rare-154600386.html
 Bullish
Yahoo News
Krystal Biotech, Inc. (KRYS): Promising Pipeline or Risky Gamble?
https://finance.yahoo.com/news/krystal-biotech-inc-krys-promising-145006525.html
 Neutral
Yahoo News
Longboard Stock Soars on FDA Designations for Epilepsy Drug
https://finance.yahoo.com/news/longboard-stock-soars-fda-designations-173300703.html
 Bullish
Yahoo News
J&J's Rybrevant Receives FDA Nod for Expanded Use in NSCLC
https://finance.yahoo.com/news/j-js-rybrevant-receives-fda-173200761.html
 Bullish
Yahoo News
GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines
https://finance.yahoo.com/news/gsk-meets-study-goal-co-170000493.html
 Bullish

Krystal Biotech Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Krystal and other traded companies coverage with news coverage. We help investors stay connected with Krystal headlines for the 25th of November to make an informed investment decision based on correlating the impacts of news items on Krystal Stock performance. Please note that trading solely based on the Krystal Biotech hype is not for everyone as timely availability and quick action are needed to avoid losses.
Krystal Biotech's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Krystal Biotech investors visualize upcoming and past events in order to time the market based on Krystal Biotech noise-free hype analysis.
Krystal Biotech stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Krystal earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Krystal Biotech that are available to investors today. That information is available publicly through Krystal media outlets and privately through word of mouth or via Krystal internal channels. However, regardless of the origin, that massive amount of Krystal data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Krystal Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Krystal Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Krystal Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Krystal Biotech alpha.

Krystal Largest EPS Surprises

Earnings surprises can significantly impact Krystal Biotech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2018-03-12
2017-12-31-0.23-0.26-0.0313 
2019-05-06
2019-03-31-0.33-0.290.0412 
2019-03-12
2018-12-31-0.23-0.27-0.0417 
2019-08-05
2019-06-30-0.32-0.37-0.0515 
2021-03-01
2020-12-31-0.59-0.530.0610 
2020-08-10
2020-06-30-0.47-0.370.121 
View All Earnings Estimates

Krystal Biotech Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Krystal Biotech Stock. Current markets are strongly bullish. About 89% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
21st of November 2024
Jennison Associates LLC Sells 110,333 Shares of Krystal Biotech, Inc. - MarketBeat
at news.google.com 
Gurufocus Stories at Macroaxis
15th of November 2024
Redmile Group, LLC Adjusts Stake in Stoke Therapeutics Inc
at gurufocus.com 
Gurufocus Stories at Macroaxis
13th of November 2024
FMR LLCs Strategic Acquisition of Krystal Biotech Inc Shares
at gurufocus.com 
Google News at Macroaxis
11th of November 2024
Krystal Biotech Scores Relative Strength Rating Upgrade - Investors Business Daily
at news.google.com 
news
7th of November 2024
Krystal Biotech Q2 EPS Forecast Increased by William Blair
at thelincolnianonline.com 
Gurufocus Stories at Macroaxis
5th of November 2024
Krystal Biotech Inc Q3 2024 Earnings Call Highlights Strong Revenue Growth and ...
at gurufocus.com 
zacks News
4th of November 2024
Krystal Biotech, Inc. Beats Q3 Earnings and Revenue Estimates
at zacks.com 
benzinga news
30th of October 2024
100 Invested In This Stock 5 Years Ago Would Be Worth 400 Today
at benzinga.com 
zacks News
23rd of October 2024
PFE Gets FDA Nod for Expanded Use of RSV Vaccine Abrysvo
at zacks.com 
benzinga news
27th of September 2024
SAGE, BIIB End Collaboration for Neurology Candidate SAGE-324
at benzinga.com 
zacks News
9th of September 2024
IMVT Stock Up on Upbeat Data From Graves Disease Study of Batoclimab
at zacks.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Krystal Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Krystal Biotech's short interest history, or implied volatility extrapolated from Krystal Biotech options trading.

Additional Tools for Krystal Stock Analysis

When running Krystal Biotech's price analysis, check to measure Krystal Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krystal Biotech is operating at the current time. Most of Krystal Biotech's value examination focuses on studying past and present price action to predict the probability of Krystal Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krystal Biotech's price. Additionally, you may evaluate how the addition of Krystal Biotech to your portfolios can decrease your overall portfolio volatility.